This proposal focuses on the regulation of the growth and function of cloned antitumor lymphocytes. The experiments over the last three years have demonstrated that lytic activity of a population of cells varies over a continuum of lytic efficiency at the level of individual cells rather than by alteration of the ratio of highly lytic/non lytic cells. The only soluble factor necessary for the regulation of an individual cell's lytic capacity is interleukin 2 (IL-2). The mechanism of IL-2 regulation appears to be through a general stimulation of protein synthesis rather than through the selective regulation of relevant genes. In addition we have found evidence for the differential regulation of lymphocyte sub classes by different lymphokines. We will pursure these studies with clonal models of different lymphocyte sub classes. In addition we will pursue similar studies with selected normal lymphocytes at different states of activation. Based on experiments with clones that cross react with multiple antigens we have developed a model for the differential regulation of growth and lytic responses by the avidity of the interaction between the CTL and an antigen bearing cell. Thus a weak interaction is optimal for stimulation of proliferation while stronger interactions are optimal for the stimulation of a lytic response. This differential regulation of responses allows for antigen presentation by weak antigenic species within the lymphoid system and limits lytic activity to the tumor, infection or graft site. In addition factors such as interferon that regulate class I antigen expression on the target cell produce an increased effectiveness of the lytic process at the anatomical site of attack. Finally we demonstrate that the antigen specific interaction can have a negative as well as a positive influence on CTL growth. This negative effect appears to be a direct effect on the responding cell itself rather than a secondary effect of soluble agents. The negative effect on growth is through an antigen-induced non responsiveness to IL-2. An understanding of the mechanism of an antigen induced block in proliferation may yield important information about the nature of one form of the induction of tolerance.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034817-06
Application #
3172646
Study Section
Immunobiology Study Section (IMB)
Project Start
1983-05-01
Project End
1990-11-30
Budget Start
1988-05-01
Budget End
1990-11-30
Support Year
6
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Russell, J H; Meleedy-Rey, P; McCulley, D E et al. (1990) Evidence for CD8-independent T cell maturation in transgenic mice. J Immunol 144:3318-25
Juszczak, R J; Russell, J H (1989) Inhibition of cytotoxic T lymphocyte-mediated lysis and cellular proliferation by isoquinoline sulfonamide protein kinase inhibitors. Evidence for the involvement of protein kinase C in lymphocyte function. J Biol Chem 264:810-5
Russell, J H; Manning, D E; McCulley, D E et al. (1988) Antigen as a positive and negative regulator of proliferation in cytotoxic lymphocytes. A model for the differential regulation of proliferation and lytic activity. J Immunol 140:1796-801
Simmons, B M; Stahl, P D; Russell, J H (1987) In vivo depletion of mannose receptor bearing cells from rat liver by ricin A chain: effects on clearance of beta-glucuronidase. Biochem Biophys Res Commun 146:849-54
Simmons, B M; Stahl, P D; Russell, J H (1986) Mannose receptor-mediated uptake of ricin toxin and ricin A chain by macrophages. Multiple intracellular pathways for a chain translocation. J Biol Chem 261:7912-20
Russell, J H; Meleedy-Rey, P; Banes, S et al. (1986) Expression of antigen interaction structures on resting and activated cytotoxic lymphocytes. Cell Immunol 103:375-80
Howe, R C; Milstone, D S; Ratliff, T L et al. (1985) Interleukin 2-mediated induction of lytic activity in a cloned murine CTL line. J Immunol 134:2414-8
Taylor, A S; Sprecher, H; Russell, J H (1985) Characterization of an arachidonic acid-selective acyl-CoA synthetase from murine T lymphocytes. Biochim Biophys Acta 833:229-38
Taylor, A S; Morrison, A R; Russell, J H (1985) Incorporation of 5,8,11,14-eicosatetraynoic acid (ETYA) into cell lipids: competition with arachidonic acid for esterification. Prostaglandins 29:449-58